HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

Human Cytomegalovirus Infection Induces a Rapid and Sustained Change in the Expression of NK Cell Receptors on CD8+ T Cells

(2014) A. van Stijn et al.   JOURNAL OF IMMUNOLOGY

HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

(2010) E. M. de Kruijf et al.   JOURNAL OF IMMUNOLOGY

The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress

(2010) Thorbald van Hall et al.   MICROBES AND INFECTION

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions

(2009) Trinidad Garcia-Iglesias et al.   BMC CANCER

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

(2009) R. Karim et al.   CLINICAL CANCER RESEARCH

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia

(2009) Andrea Velardi et al.   CURRENT OPINION IN IMMUNOLOGY

Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer

(2009) Ninke Leffers et al.   GYNECOLOGIC ONCOLOGY

Expression of NK cell receptors on decidual T cells in human pregnancy

(2009) Tamara Tilburgs et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

(2008) Kui Li et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer

(2008) Ninke Leffers et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

(2008) E. S. Jordanova et al.   CLINICAL CANCER RESEARCH

Classical and non-classical HLA molecules and p16INK4a expression in precursors lesions and invasive cervical cancer

(2008) Maria Alice G. Gonçalves et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer

(2008) Sonja Textor et al.   INTERNATIONAL JOURNAL OF CANCER

Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression

(2008) Min Liu et al.   MODERN PATHOLOGY

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE

The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity

(2008) L. C. Sullivan et al.   TISSUE ANTIGENS